DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Kumar SK, Lee JH, Lahuerta JJ, Morgan G, Richardson PG, Crowley J. et al.
Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study.
Leukemia 2012;
26: 149-57
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.